About Corden Pharma
Corden Pharma is a company based in Plankstadt (Germany) founded in 2006 was acquired by International Chemical Investors in February 2013. Corden Pharma has completed 2 acquisitions, including AmbioPharm and Ancora Pharmaceuticals. Corden Pharma offers products and services including APIs, Drug Products, and Lipid Excipients. Corden Pharma operates in a competitive market with competitors including Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.
- Headquarter Plankstadt, Germany
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website cordenpharma.com
- Social LinkedIn Facebook YouTube
- Acquired by International Chemical Investors (Feb 2013)
- Investors
- Investments & AcquisitionsAmbioPharm
& 1 more
- Acquired byInternational Chemical Investors
(Feb 2013)
Products & Services of Corden Pharma
Corden Pharma offers a comprehensive portfolio of products and services, including APIs, Drug Products, and Lipid Excipients.
Development and manufacturing of drug substances for pharmaceuticals
Production of sterile and non-sterile forms for drug delivery
Creation of lipid-based products for pharmaceutical formulations
Apps and channels of Corden Pharma
its YouTube channel CordenPharma has 17 subscribers and 29 videos.
Videos from Corden Pharma
The most watched videos on Corden Pharma's YouTube channel, CordenPharma (17 subscribers). Click a video to play it here.
More on CordenPharma.
Investors in Corden Pharma
Corden Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include International Chemical Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A privately owned industrial group focused on chemical investments. | – | ic-investors.com | Frankfurt, Germany |
Investor details for Corden Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Corden Pharma
153 people are tracked at Corden Pharma (50 in leadership, 103 in team).
| Name | Role | Group |
|---|---|---|
Phillip Chalabi | Vice President, Head Of North America Sales | Leadership |
Poly Ouma | CFO And Head Of Procurement & Master Data, Cordenpharma Colorado Inc. | Leadership |
Karsten Meyenberg | Site Head - Frankfurt | Leadership |
Pierre Muller | Head Of Quality / Responsible Person | Leadership |
Ludovic Thivillier | Head Of Supply Chain | Leadership |
Chris Burkitt | Head Of Group Controlling, Reporting & Fp&a | Leadership |
Thomas Müller | Managing Director Corden Pharma Switzerland LLC | Leadership |
Alexandre Lavigne | Head Of PMO & Customer Service | Leadership |
Michele Sammarco | PMO Director | Leadership |
James Leresche | Managing Director | Leadership |
Dario Bello | Head Of Finance And Administration | Leadership |
Matthias Bachhelm | Senior Director, Global Head Of Key Account Management | Leadership |
Steffen Bira | Associate Director, Sales & Key Account Management | Leadership |
Alain Hildebrandt | Head Of Quality Control | Leadership |
Martin Hagen | Head Of Manufacturing And Operations | Leadership |
Joel Vannieuwenhove | Head Of Operations | Leadership |
Timothy Woodcock | Director Of Procurement | Leadership |
Mimoun Ayoub | Senior Vp, Global Head Of Sales & Key Account Management | Leadership |
Valeria Millasson | Global Head Of Operational Excellence Drug Products | Leadership |
Sandro Leserri | Head Of Manufacturing | Leadership |
133 more people are available in the full profile.
Complete people profiles for Corden Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Corden Pharma
Corden Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include AmbioPharm and Ancora Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
CDMO and analytical services for peptide development are provided. | ambiopharm.com | North Augusta, United States | 2006 | May 2026 | •••• | |
Vaccines for hospital-acquired infections are developed in preclinical stages. | ancorapharma.com | Milton Keynes, United Kingdom | 2002 | Oct 2013 | •••• |
Complete acquisition details for Corden Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Corden Pharma
4 dated milestones of Corden Pharma across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Corden Pharma is founded.
- Exit Acquired by International Chemical Investors.
- Acquisition Acquires Ancora Pharmaceuticals.
- Acquisition Acquires AmbioPharm.
Competitors of Corden Pharma
Corden Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| almacgroup.com | 2001 | Craigavon, United Kingdom | $338.8M | 2,109 | Integrated CDMO services for biopharma R&D and manufacturing are offered. | |
| asymchem.com | 1995 | Morrisville, United States | – | 48 | APIs and peptides are developed and manufactured by Asymchem. | |
| seqens.com | 2003 | Ecully, France | – | 44 | Contract manufacturing services for small molecules and peptides are provided. | |
| aurobindo.com | 1986 | Hyderabad, India | – | 1,010 | Generic biocatalytic solutions are provided for pharmaceutical applications. | |
| aptuit.com | 2004 | Greenwich, United States | $14.23M | – | Contract research and development services for small molecules are offered. | |
| indoco.com | 1947 | Mumbai, India | – | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | |
| concordbiotech.com | 2000 | Ahmedabad, India | – | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | |
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | |
| pharm-int.com | 1994 | Hunt Valley, United States | $171.23M | 248 | Pharmaceutical dosage forms are manufactured by this CDMO. |
Detailed competitors of Corden Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Corden Pharma
The website of Corden Pharma (cordenpharma.com) receives about 26.2K visits a month and ranks #789,402 among all websites worldwide, #936 in Biotechnology and Pharmaceuticals.
- Monthly visits26.2K
▼ 24.1% vs previous month
- Unique visitors12.8K
per month
- Global rank#789,402
among all websites
- Category rank#936
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit2.9
- Average visit1 min 15 sec
- DevicesDesktop 30% · Mobile 70%
Websites whose visitors overlap most with Corden Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bachem.com | 100% | 167.9K | #280,794 | View details | |
| stpharm.co.kr | 93% | 15.8K | #1,807,075 | View details | |
in-pharmatechnologist.com | in-pharmatechnologist.com | 92% | – | – | – |
| coraldrugs.com | 87% | 680.7K | #11,178,852 | View details | |
| adienne.com | 87% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 23 similar websites and full traffic analytics for Corden Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 23 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Corden Pharma
Complete news archive for Corden Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Corden Pharma
10 companies that operate in the same segment as Corden Pharma (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Corden Pharma
Corden Pharma was founded in 2006.
Corden Pharma is headquartered in Plankstadt, Germany. It is registered at Plankstadt, Baden-wurttemberg, Germany.
CordenPharma is a full-service partner in the Contract Development and Manufacturing (CDMO) of APIs, Drug Products and associated Packaging, Logistics, and Clinical Supply Services. Through their network of fully-inspected cGMP facilities across Europe and the US which are organised under six technology platforms namely, Antibiotics, Highly Potent Oncology Products, Small Molecules, PeptidesLipids Carbohydrates, Injectables, Fermentation Enzymes they offer product development and manufacturing services. The company has facilities in Italy, US, Germany, France, Belgium and Switzerland. CordenPharma claims that it can translate complex ideas at any stage of development into high-value products. CordenPharma specialises in the development of oncology drugs(Sterile and Oral dosage forms, including HPAPIs) and fermentation based small molecules.
Corden Pharma's top competitors include Concord Biotech, Almac Group and Indoco Remedies.
Corden Pharma offers APIs, Drug Products, and Lipid Excipients.
Corden Pharma has made 2 acquisitions, including AmbioPharm, and Ancora Pharmaceuticals.
Corden Pharma has 1 investor. Key investors include International Chemical Investors.
Yes. Corden Pharma was acquired by International Chemical Investors in February 2013.